Smithtown Assisted Living
(516) 265-7793
AxSpA/PsA: Early Response Predicts Longterm Response to Certolizumab (CME/CE)
(MedPage Today) -- Achieving longterm targets in axial spondyloarthritis/psoriatic arthritis unlikely without early response
via
AxSpA/PsA: Early Response Predicts Longterm Response to Certolizumab (CME/CE)
by
Newer Post
Older Post
Home